Aligos Therapeutics, Inc.
Aligos Therapeutics, Inc. (ALGS) is a publicly traded company in the Unknown sector. Across all available filings, 11 corporate insiders have executed 67 transactions totaling $23.3M, demonstrating a bullish sentiment with $23.3M in net insider flow. The most recent transaction on Oct 25, 2023 involved a transaction of 183,083 shares valued at $139.1K.
ALGS Insider Activity Summary
Who Is Buying ALGS Stock?
No significant insider buying has been recorded for ALGS in the recent period.
Who Is Selling ALGS Stock?
No significant insider selling has been recorded for ALGS in the recent period.
Is Aligos Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for ALGS is bullish with an Insider Alignment Score of 100/100 and a net flow of $23.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
ALGS Frequently Asked Questions
Understanding ALGS Insider Activity
Insider trading at Aligos Therapeutics, Inc. (ALGS) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 11 insiders are actively trading ALGS stock, having executed 67 transactions in the past 90 days. The most active insider is Capital Surplus Fund Viii, L.p. Vivo (Executive), who has made 8 transactions totaling $8.3M.
Related Tools
Track Aligos Therapeutics, Inc. Insider Activity
Get notified when executives and directors at ALGS file new Form 4 transactions